Karachi-based Dawaai, the on-line pharmaceuticals startup in Pakistan closed its series A funding at the end of March. It is on the way to turning a profit by the end of the year as the pharmaceuticals and medical supplies aggregator rushes to meet demand generated by the Covid-19 pandemic.
As last year drew to a close, FinanceAsia investigated which Chinese private equity and venture capital investors ran the most successful RMB funds during the ten years from 2009 to 2019. We reveal the results today and interview the managers who achieved such stellar performances.
Each Friday afternoon starting today, FinanceAsia will pen an editorial highlighting our unique capital markets news from the past week and place them in context of the bigger picture for the months ahead. We welcome your comments and criticisms. It is the best way to start the weekend.